Skip to main content
. Author manuscript; available in PMC: 2016 Jan 7.
Published in final edited form as: Ann Intern Med. 2015 Jul 7;163(1):22–31. doi: 10.7326/M14-2057

Table 2.

Association of Lesions and White Matter Hyperintensities (WMH) with Incident Stroke, Stroke Subtypes, Mortality, and Stroke Among ARIC Participants*

Stroke (ANY)
N=157 (8%)
Ischemic Stroke
N=140 (7%)
Hemorrhagic Stroke
N=15 (1%)
All-cause mortality
N=576 (31%)
Stroke Mortality
N=50 (10%)

Lesion Type

  None
  (N=1611, 86%)
-ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref-

  Very small (<3mm Only)
  (N=50, 3%)
3.47 (1.86, 6.49) <0.001 3.10 (1.57, 6.12) 0.001 17.25 (4.05, 73.46) <0.001 1.34 (0.84, 2.13) 0.217 3.05 (1.04, 8.94) 0.043

  Larger (≥3mm Only)
  (N=185, 10%)
1.94 (1.22, 3.07) 0.005 1.83 (1.12, 2.99) 0.015 2.60 (0.47, 14.49) 0.276 1.90 (1.48, 2.44) <0.001 1.87 (0.83, 4.23) 0.132

  Both (Very Small & Larger)
  (N=35, 2%)
8.59 (4.69, 15.73) <0.001 6.88 (3.58, 13.22) <0.001 26.67 (5.21, 136.46) <0.001 1.89 (1.14, 3.13) 0.013 6.97 (2.03, 23.93) 0.002

Any Lesions <3mm
(N=85, 5%) vs no lesions
4.94 (3.08, 7.92) <0.001 4.17 (2.51, 6.94) <0.001 21.64 (6.19, 75.73) <0.001 1.49 (1.04, 2.13) 0.031 5.14 (2.08, 12.73) <0.001

Count of Lesions <3mm

  0 (N=1611, 95%) -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref-

  1 to 2 (N=73, 4%) 4.87 (2.99, 7.93) <0.001 4.03 (2.37, 6.85) <0.001 20.27 (5.55, 73.97) <0.001 1.39 (0.94, 2.06) 0.095 5.87 (2.33, 14.78) <0.001

  >2 (N=12, 1%) 5.72 (1.64, 19.94) 0.006 5.73 (1.62, 20.24) 0.007 § § 2.13 (0.98, 4.66) 0.058 § §

Any Lesions ≥3mm
(N=220, 12%) vs no lesions
2.54 (1.70, 3.79) <0.001 2.35 (1.54, 3.60) <0.001 6.42 (1.68, 24.44) 0.006 1.88 (1.48, 2.37) <0.001 2.63 (1.25, 5.52) 0.011

  Any Non-lacunes ≥3mm
  (N=32, 2%)
4.92 (2.31, 10.49) <0.001 5.41 (2.52, 11.61) <0.001 16.40 (1.52, 177.32) 0.021 3.90 (2.35, 6.46) <0.001 § §

  Any Lacunes 3–20mm
  (N=188, 10%)
2.30 (1.49, 3.55) <0.001 2.04 (1.28, 3.25) 0.003 7.14 (1.63, 31.34) 0.009 1.69 (1.31, 2.17) <0.001 3.33 (1.57, 7.05) 0.002

  # of Lacunes 3–20mm

    0 (N=1611, 90%) -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref-

    1 (N=132, 7%) 1.81 (1.06, 3.08) 0.029 1.83 (1.05, 3.16) 0.032 2.46 (0.26, 23.71) 0.436 1.47 (1.09, 1.98) 0.012 1.94 (0.78, 4.86) 0.155

    ≥2 (N=56, 3%) 3.64 (1.98, 6.69) <0.001 2.58 (1.26, 5.28) 0.009 23.24 (3.96, 136.48) <0.001 2.36 (1.59, 3.50) <0.001 11.71 (4.10, 33.47) <0.001

WMH (Grades 0–9) 1.30 (1.15, 1.46) <0.001 1.30 (1.14, 1.47) <0.001 1.42 (0.99, 2.03) 0.054 1.20 (1.12, 1.29) <0.001 1.35 (1.10, 1.66) 0.004

    WMH Grade (high vs low)

    Low <3 (N=1658, 88%) -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref- -ref-

    High ≥3 (N=223, 12%) 2.14 (1.45, 3.16) <0.001 2.12 (1.41, 3.20) <0.001 3.13 (0.93, 10.54) 0.066 1.78 (1.42, 2.23) <0.001 2.47 (1.25, 4.87) 0.009
*

Values in table are HRs (95% CI) from Cox PHMs adjusted for age, sex, race-site, education, BMI, smoking, alcohol, diabetes, systolic and diastolic blood pressures, hypertension medication use, heart disease, HDL, LDL, triglycerides, statin use; all estimates compared to reference group of “no lesions” (n=1611) except WMH.

Lacunes = 3–20 mm lesions in the basal ganglia, brain stem, thalamus, internal capsule, or cerebral white matter (including those who may also have small infarcts); non-lacunar lesions were any lesions 3–20 mm not located in these areas or >20 mm in any area on right-to-left or anterior-to-posterior measurements

Includes 31 participants who also had a very small lesion (<3mm)

§

Too few data to support estimates